Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02573766 · ClinicalTrials.gov registry record · NA

Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy

A NA study of Pain, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
91
Enrollment target
1
Study location

NCT02573766: Active NA study of Pain, sponsored by M.D. Anderson Cancer Center.

NCT02573766 is a NA study of Pain that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 91 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02573766, a NA study of Pain, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
91 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is to learn if using a type of non-invasive therapy called neurofeedback training can help teach patients with peripheral neuropathy how to change their own brain waves to lower their perception of neuropathy and help improve their overall quality of life. Neurofeedback training is a type of therapy that uses an electroencephalograph (EEG) and a computer software program to measure brain wave activity. This is an investigational study. The equipment used for neurofeedback training is FDA approved and commercially available. Using neurofeedback equipment to teach patients ways to modify their own brain waves to lower the perception of symptoms and improve quality of life is considered investigational. Up to 99 participants over the age of 18 will take part in this study. All will be enrolled at MD Anderson.

Conditions Studied

Pain

Interventions

  • BEHAVIORAL Questionnaires
  • PROCEDURE Neurofeedback Training
  • PROCEDURE Electroencephalogram
  • BEHAVIORAL Pain Scale

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2015-10-01
Est. Completion 2026-10-01
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02573766

The ClinicalTrials.gov registry entry for NCT02573766 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (70% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires is the first listed.

NCT02573766 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02573766 about?

NCT02573766 is a clinical study titled "Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy". The goal of this clinical research study is to learn if using a type of non-invasive therapy called neurofeedback training can help teach patients with peripheral neuropathy how to change their own brain waves to lower their perception of neuropathy and help improve their overall quality of life. N...

What is the current status of trial NCT02573766?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 91 participants. The study started on 2015-10-01. Estimated completion is 2026-10-01.

What conditions does trial NCT02573766 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02573766?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Neurofeedback Training (PROCEDURE), Electroencephalogram (PROCEDURE), Pain Scale (BEHAVIORAL).

Who is sponsoring clinical trial NCT02573766?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02573766 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.